Topics
Sector
Geography
Subject

Videos Library

All Videos

1457
videos of thought-leading presentations and interactive panel discussions from life science industry visionaries and experts

The NextLevel LifeSciences Videos Library is the full collection of video recordings (and supporting documentation) from all NextLevel LifeSciences events.

Latest Videos

Presentation

Changing Trends in Real World Evidence

Related topics: Pharmaceutical/Biotech, Market Access & HEOR, Real-World Evidence & Late-Phase Research
Availability: FREE
  • Payer expectations.
  • The regulatory landscape.
  • Access to data.
  • The Increasing voice of the patient.
  • What is in store for sponsor-CRO partnerships?
Speaker

Noolie Gregory
Exec Dir, Client Engagement
Syneos Health, UK

Presentation

Early Access Programs – as a valuable component of market access and launch strategy

Related topics: Pharmaceutical/Biotech, Market Access & HEOR, Clinical
Availability: FREE
  • Understand how these programs have been used extensively by pharma companies to address unmet medical need, but have broader market access benefits including another source of real world data.  This session will help people understand the basics about EAPs, the current landscape and industry trends around EAPs, and the types of data that various companies are capturing.  A case study will be provided.
Speaker

Kieron Lewis
Global Business Development Director
Clinigen, UK

Presentation

Facilitating innovative pricing, value based reimbursement and personalised medicine using revolutionary blockchain technology

Related topics: Pharmaceutical/Biotech, Market Access & HEOR, IT & Big Data
Availability: FREE
  • A new paradigm: Introduction to blockchain technology and its applications in healthcare
  • Digipharm: overcoming barriers to innovative pricing solutions and value based reimbursement
  • Innovative evidence generation and the impact on pricing & reimbursement
Speaker

Ahmed Abdulla
CEO
Digipharm, Switzerland

Presentation

Market access for (very high cost) rare disease or transformative therapies: changing our mindset

Related topics: Pharmaceutical/Biotech, Market Access & HEOR, Orphan Drugs
Availability: FREE
  • Aggregated budget impact of these therapies
  • Funding and contracting approaches
  • Value-based thinking
Speakers

Akshay Kumar
Principal Consultant
Pope Woodhead, UK

Eugenia Priedane
Senior Consultant
Pope Woodhead, UK

Presentation

Adaptive, Umbrella and Basket studies - What are they, Why are they needed, and how will payers receive them?

Related topics: Pharmaceutical/Biotech, Market Access & HEOR
Availability: FREE

There is a well-recognized long-standing decline in R&D productivity in the pharmaceutical industry which has driven exploration of new approaches to the clinical development of pharmaceuticals.  These include innovative randomized controlled trial designs, including adaptive, umbrella, and basket studies. Adaptive trials, perhaps the best established of these, have already been the subject of guidance documents by both the European Medicines Agency and Food and Drug Administration. However, in many markets it is the reimbursement hurdle (rather than the regulatory hurdle) that is proving the major barrier to overcome in order to enable patient access. Therefore, payer perceptions on such innovative trial designs will be key to informing pharmaceutical company utilization of such approaches. This presentation will provide an overview of these innovative new designs and present payer perspectives on the benefits and challenges posed by conducting reimbursement assessments on data coming from these trial designs, based on discussions with a German and UK payer.

Speakers

Janice Haigh
VP Pricing & Market Access
Parexel Access Consulting

 

Richard Macaulay
Principal Consultant, (Pricing and Market Access)
Parexel, UK

Presentation

Real world evidence: Opportunities and challenges with registry data

Related topics: Nordic, Market Access & HEOR, Real-World Evidence & Late-Phase Research
Availability: FREE

- Real world data solutions in the post-marketing world: the multiple sclerosis experience

- Introduction to the MSBase international registry

- Methods for separating drug signals from bias in observational data

- Pharma / disease registry collaborations in comparative effectiveness analyses

- Big data: Big MS and beyond

Speaker

Tim Spelman
Senior Scientist
Synergus

Presentation

Leading MSLs to the best of their potential

Related topics: Medical Affairs & Stakeholder Engagement, Medical Science Liaison
Availability: FREE
  • Internal training
  • Engagement tool
  • Keeping the conversation going
Speakers

Annie Rankin
Client Partnerships Lead
Succinct Medical Communications

Gavin Kenny
Account Director
Succinct Medical Communications

Presentation

The power of consistent communication with HCPs and patients

Related topics: Medical Affairs & Stakeholder Engagement, Patient-Centricity & Care
Availability: FREE
  • Keeping consistency in communications with both HCPs and patients to maximise high quality patient-HCP conversations
Speakers

Katie Corbin
Managing Director
Succinct Medical Communications

Richard Jones
Patient Services Director
The Earthworks (an OPEN Health Company)

Presentation

Multichannel strategy and behavioural science: perfect partners for smarter communications

Related topics: Medical Affairs & Stakeholder Engagement
Availability: FREE
  • Appreciate the importance of understanding human behaviour in designing effective and affective medical communications
  • Recognise the synergistic benefits of bringing behavioural insights and multichannel strategy together for smarter, more targeted communications
  • Challenge your communications strategy: not doing things ‘because we’ve always done it this way’, looking critically at the end goals, the behavioural context and barriers, and designing a smart multichannel strategy
Speakers

Louise Picken
Senior Scientific Director
Complete HealthVizion

Robert Poole
Director of Scientific Services
Complete HealthVizion

Presentation

The art and science of designing a RWD project

Related topics: Medical Affairs & Stakeholder Engagement, Real-World Evidence & Late-Phase Research
Availability: FREE
  •  The hidden link between product strategy and scientific approach
  • Challenges and opportunities in dealing with many stakeholders
  • Prioritizing multiple interests in one “finer” research question
  • A project design workflow for clinical research with RWD
Speaker

Giovanni Fiori
Managing & Scientific Director
MediNeos

Presentation

Promoting the patient voice in evidence generation and global market access planning

Related topics: Medical Affairs & Stakeholder Engagement, Real-World Evidence & Late-Phase Research, Patient-Centricity & Care
Availability: FREE
  • Regulator and payer perspectives on patient-centric data in decision making.
  • Highly successful strategies for leveraging the patient voice in RWE research.
Speakers

Leanne Larson
Corporate VP, Observational Research
PAREXEL

Richard Macaulay
Principal Consultant, (Pricing and Market Access)
Parexel, UK

Presentation

The changing trends in real-world Evidence

Related topics: Medical Affairs & Stakeholder Engagement, Real-World Evidence & Late-Phase Research
Availability: FREE
Speaker

Maryna Kolochavina
Project Director, Real World & Late Phase
Syneos Health

Presentation

Increasing the efficiency of your Medical Affairs Team: The Silent Time Killer of Copy Review

Related topics: Medical Affairs & Stakeholder Engagement
Availability: FREE
  • Case Study: How outsourcing can unburden your team to focus on value-adding relationships
Speaker

Tessa Pugh
Director
PharmaReview, UK

Presentation

From NPS to an actionable customer centric listening program: A global approach

Related topics: MedTech, Commercial
Availability: FREE
  • Moving beyond NPS
  • Engaging a global team to get local customer insight
  • Maintaining the focus on the customer
  • Driving the global process forward.
  • It’s not just the numbers: Tell the story of the customer
Speakers

Shane West
VP Client Relations
Cetas Healthcare Insights, Norway

Dushyant Gupta
Senior Client Engagement Director
Cetas Healthcare Insights, India

Presentation

Opportunities for digital technologies and services to drive value and access for Medtech

Related topics: MedTech, Commercial, Digital & Technology
Availability: FREE
  • What does the new world of medtech and digital health look like?
  • How can digital technologies and services enhance the value of devices in a meaningful way to payers?
  • How will these innovative solutions be regulated and reimbursed?
Speaker

Anne Smart
Managing Director
ClearView Healthcare Partners, USA

Presentation

Create customised digital experiences for payers and HCPs

Related topics: MedTech, Commercial, Digital & Technology
Availability: FREE

Explore how new digital technologies enhance your customer interactions and deliver real commercial benefit 

  • Understand how your customers’ needs have changed
  • Learn how digital technology enables you to respond to these new challenges
  • Explore how virtual engagement technologies create new opportunities
  • See real-life examples of how digital solutions have transformed customer relationships
  • Bringing it all together: learn how to use the data to extend commercial opportunities
Speaker

Lars U Diemer
Chief Executive Officer
Agnitio, Denmark

Presentation

The best buyer experience wins - How to use digital to leave a mark with the empowered buyer

Related topics: MedTech, Commercial, Digital & Technology
Availability: FREE
  • Empowered buyer teams force Marketing & Sales to step up their game
  • Marketing can support sales teams to become more solution-centric
  • Sales teams can go beyond the expected and impact the modern day buyer
  • Ceterix, bioMérieux and ARGEN use sales enablement technology to step change Marketing and Sales alignment and grow sales productivity.
Speaker

Orhan Dayioglu
Sales Transformation Leader
Showpad, Germany

Presentation

The Journey of a Top 20 MedTech Sales Enablement Project

Related topics: MedTech, Commercial
Availability: FREE
  • Situation before the project start
  • Evaluation process and piloting
  • Implementation approach
  • Outlook for the future
Speaker

Arik Brückner
Commercial Director
Pitcher AG

Presentation

Elevating the market access competency to maximize business impact

Related topics: MedTech, Market Access & HEOR, Commercial
Availability: FREE
  • Becoming an integral partner in strategic business decision making
  • Organizing the competency in today’s value-based healthcare (VBHC) environment
  • Case studies
Speaker

Rob Wenthold
Vice President
Boston Healthcare

Presentation

Value-Based Selling: are we there yet?

Related topics: MedTech, Market Access & HEOR, Commercial
Availability: FREE
  • What is Value and how to quantify it?
  • “Doctors love my product, but I still cannot sell it” - an evolving balance of power
  • Do I need Reimbursement? What are the risks?
  • “Your product is too expensive”: fact or misperception?
  • Case example: from “easy-to-use” to “cost-saving”
  • Practical recommendations for Value-Based Sales
Speaker

Ben Modley
Director of European Operations
Value Connected, Germany

Presentation

Successful marketing claims in current regulatory environment

Related topics: MedTech, Commercial, Regulations & Ethics
Availability: FREE
  • Current and future regulatory environment
  • How is the industry geared to address these changes?
  • What are the constructs of an ideal marketing claims strategy?
  • What are the gold standard practices for marketing claims?
  • How to deal with unsuccessful claims?
Speakers

Sumit Mehta
Managing Director
Cetas Healthcare Insights, Singapore

Claus Schaffrath
Consultant & Founder
Cetas Healthcare & MD squared, The Netherlands

Presentation

Transforming to a Customer Centric Go-to- Market Model in Med Tech

Related topics: MedTech, Commercial, Patient-Centricity & Care
Availability: FREE
  • Understanding the shifting buyer universe.
  • Defining the organisation of the future.
  • Key challenges & opportunities when transforming your business around the customer.
  • Outlining different transformation pathways depending on your organisational imperative & operational maturity.
Speakers

Mark Taylor
Director, EMEA
Blackdot, UK

Linton Chalmers
EMEA Practice Lead, Capability & People Advisory
Blackdot, UK

Presentation

Challenges and opportunities for successful Real World Evidence strategy

Related topics: Pharmaceutical/Biotech, MedTech, Real-World Evidence & Late-Phase Research, IT & Big Data
Availability: FREE
Speaker

Nourdine Bouzekri
Principal Industry Consultant
SAS, France

Presentation

Putting the patient/citizen into the driving seat

Related topics: Pharmaceutical/Biotech, MedTech, Real-World Evidence & Late-Phase Research, IT & Big Data
Availability: FREE
  • The key elements to leverage the potential of electronic health care data: Where is the trust?
  • Regulations which might support it: GDPR and other regulations
  • Who are the partners/stakeholders and their major responsibilities?
  • Democratization of the analytics and data: Patients view and the citizen handle it?
  • Ethical consideration about not being in a position using the data: Another view or how interests might need a balance and who might be in charge?
Speaker

Peter Grolimund
Sr. Life Science Industry Consultant
ThinkBig Analytics (a Teradata company)

Presentation

Artificial intelligence for drug discovery, biomarker development and aging research

Related topics: Pharmaceutical/Biotech, MedTech, Diagnostics, IT & Big Data, Discovery & R&D Innovation
Availability: FREE
Speaker

Alex Aliper
President
Insilico Medicine

Presentation

The Sentient Enterprise or ‘Sentient’ healthcare as a vision in using data

Related topics: Pharmaceutical/Biotech, MedTech, Market Access & HEOR, Real-World Evidence & Late-Phase Research, IT & Big Data, Discovery & R&D Innovation
Availability: FREE
  • Another approach to personalised medicine and outcome-based reimbursement: The sentient healthcare enterprise.
  • The technology and trends to get there.
  • The data and analytical democracy of all stakeholders.
  • The major challenges and how to handle those in order to manage the healthcare costs.
  • Examples from other industries.
Speaker

Stephen A. Brobst
CTO
Teradata Corporation

Presentation

Enabling economic selling

Related topics: MedTech, Market Access & HEOR, Commercial, Global (non-specific)
Availability: FREE
  • What is the role of market access in economic selling?
  • The challenge of quantifying value.
  • Building effective tools and training methods.
  • Partnering with commercial teams.
  • Case studies: Selling value in the UK and Germany.
Speaker

Ernesto M. Nogueira
Managing Director
Value Connected, Netherlands

Presentation

Real World Evidence the key to smart medical device market access

Related topics: MedTech, Europe, Market Access & HEOR, Real-World Evidence & Late-Phase Research
Availability: FREE
  • It is all about the quality of the data.
  • RWE to understand target indication and plausibility of clinical trial success.
  • Single arm / registry to comparative effectiveness data.
Speaker

Mattias Kyhlstedt
CEO
Synergus AB, Denmark

Presentation

How to balance evidence demands between US and International Markets

Related topics: MedTech, Europe, USA, Market Access & HEOR
Availability: FREE

Planning for a global product launch means a coherent evidence plan and value dossier must address the needs of multiple geographies. This session will review the evolving perspectives of US payers on evidence for medical devices, and contrast these trends with major EU markets and Japan. Specific topics to be addressed will include:

  • US Medicare and private payer bundled payment models.
  • New bundling of In Vitro Diagnostics under Medicare outpatient rules.
  • British requirements for Specialised Services.
  • French programs to generate real world evidence.
  • Germany’s trial regulation.
  • Japan’s new HTA requirements.
Speaker

Stephen Hull
Principal and Founder
Hull Associates, USA

Presentation

Preparing commercial teams to demonstrate value, not features

Related topics: MedTech, USA, Commercial
Availability: FREE
  • More professional purchasers and decision makers need a different approach
  • Why price is not the priority for providers (even though it seems so)
  • Developing the value message: Quantifying benefits
  • Roadmap to preparing commercial teams to use value to justify price
  • Best practices from real case studies
Speaker

Ernesto M. Nogueira
Managing Director
ValueConnected

Presentation

Embedding market access into the mergers & acquisitions process

Related topics: MedTech, USA, Market Access & HEOR
Availability: FREE
  • Market access supporting key value processes
  • The mergers & acquisitions process
  • Key issues examined during due diligence
  • Anonymised case studies
Speaker

Rob Wenthold
Vice President
Boston Healthcare Associates

Presentation

Medical affairs information strategies for medical devices and how to take advantage of new requirements

Related topics: MedTech, Medical Affairs & Stakeholder Engagement, Real-World Evidence & Late-Phase Research, Global (non-specific)
Availability: FREE
Speaker

William C Maier
Chief Scientific Officer and Head of Patient-Centered Sciences
Mapi Group

Presentation

A pinch of strategy: Perfecting the recipe for success in medical affairs communications

Related topics: Medical Affairs & Stakeholder Engagement, Global (non-specific), Life Sciences (not-specific)
Availability: FREE
  • The revolution in our kitchen: The changing landscape of medical Affairs.
  • Introducing new ingredients: A new blend of responsibility for medical affairs leaders.
  • Prepare, mix, bake: Using the right approach to create an effective and affective medical affairs plan.
  • Serving suggestions: How powerful communications can change patients’ lives.
Speakers

Ian Greenway
Medical Affairs Director
Complete HealthVizion, UK

Rhiannon Meaden
Head of Commercial Development
Complete HealthVizion, UK

Presentation

Data strategy in the ever changing world of RWE and medical affairs

Related topics: Medical Affairs & Stakeholder Engagement, Real-World Evidence & Late-Phase Research, IT & Big Data, Global (non-specific), Digital & Technology, Life Sciences (not-specific)
Availability: FREE
  • Necessary conditions for better, more useful real-world data.
  • Importance of a comprehensive and robust RWE strategy, including identification of optimal data sources, methods, and data gaps.
  • The use of technology in data analytics for increased cost savings and decreased time for results
Speaker

Radek Wasiak
Vice President, Meta Research & Real-World Evidence,
Evidera Inc., UK

Presentation

Non-Interventional ≠ Not Interventional: Regulatory perspectives for real-world studies

Related topics: Medical Affairs & Stakeholder Engagement, Real-World Evidence & Late-Phase Research, Global (non-specific), Regulations & Ethics, Life Sciences (not-specific)
Availability: FREE
  • Regulatory classification of real-world studies.
  • Why are the regulations for non-interventional studies so difficult/frustrating/confusing?
  • Pragmatic clinical trials: The missing RWE link?
Speaker

Stuart McCully
VP Late Stage
INC Research/inVentiv Health, UK

Presentation

Responding to European Authorities demands: How can innovation help meet commitments?

Related topics: Medical Affairs & Stakeholder Engagement, Real-World Evidence & Late-Phase Research, Global (non-specific), Life Sciences (not-specific)
Availability: FREE
  • Post-marketing commitments: PASS, PAES.
  • Article 20s and DUS: Prospective or retrospective data.
  • ENCePP: How to make the most of it.
  • Leveraging innovation to meet commitments.
  • Real World Evidence 3.0.
Speaker

Alexandre Malouvier
Director of Scientific Affairs, Late Phase Services
PRA Health Sciences, UK

Presentation

Engaging physicians with IME/CME: Why would we?: An interactive case scenario

Related topics: Medical Affairs & Stakeholder Engagement, Global (non-specific), Life Sciences (not-specific)
Availability: FREE
  • Why medical affairs must adapt and consider this educational format to engage physicians.
  • What is the value of IME?: Benefits and considerations in funding IME/CME.
  • Interactive case study of IME, identifying best practices to providing IME/CME.
Speaker

Celeste Kolanko
Managing Director
Liberum IME, UK

Presentation

Promoting the patient voice in evidence generation and global market access planning

Related topics: Market Access & HEOR, Medical Affairs & Stakeholder Engagement, Real-World Evidence & Late-Phase Research, Global (non-specific), Life Sciences (not-specific)
Availability: FREE
  • Regulator and payer perspectives on patient-centric data in decision making.
  • Highly successful strategies for leveraging the patient voice in RWE research.
Speakers

Leanne Larson
Corporate VP, Observational Research
PAREXEL

Oliver Leatham
VP Heron Commercialization
PAREXEL

Presentation

Medical communications: Integrating the patient voice

Related topics: Medical Affairs & Stakeholder Engagement, Global (non-specific), Patient-Centricity & Care, Life Sciences (not-specific)
Availability: FREE
  • Identify key questions that should be asked when determining if medical communications are meaningful for patients.
  • Working with stakeholders to provide insights for patient-centric communications.
  • Describe two case studies that demonstrate how medical communications to patients were vastly improved by applying patient insights.
Speaker

William C Maier
Chief Scientific Officer and Head of Patient-Centered Sciences
Mapi Group

Presentation

Achieving world class execution in medical affairs

Related topics: Pharmaceutical/Biotech, Medical Affairs & Stakeholder Engagement, Life Sciences (not-specific)
Availability: FREE
  • Transformation of medical affairs to deliver greater value.
  • Executing long term engagement strategies in today’s complex disease space.
  • Developing and delivering scientific insights to achieve strategic differentiation.
Speaker

Sital Kotecha
Director, Medical Strategy
Veeva Systems, UK

Presentation

Future market access excellence: Enabling a dynamic organisation

Related topics: Pharmaceutical/Biotech, Market Access & HEOR, Global (non-specific), Capabilities & Effectiveness
Availability: FREE
  • New organisational capability needs to address major market changes.
  • Optimising global strategy and local agility: Updated planning and governance structures.
  • Cross-functional leadership and aligned KPIs.
  • Digital tools to drive efficiency, effectiveness and feedback.
Speaker

Chris Easley
Head of Market Access Solutions
Pope Woodhead and Associates Ltd.

Presentation

What’s it worth to you? Assessing value of product attributes through decision-analytic modelling

Related topics: Pharmaceutical/Biotech, Market Access & HEOR, Global (non-specific)
Availability: FREE
  • How a product’s characteristics or attributes contribute to both individual willingness to pay and “value” from different perspectives (e.g., stakeholder, society).
  • The various methodologies through which attribute value can be assessed.
  • A real-world case study of how decision-analytic modelling helped a leading medical device company establish the value of a unique product attribute, and by so doing justify higher tender pricing in a key EU market.
Speaker

Mason W. Russell
Vice President, Strategic Consulting (Life Sciences)
Truven, USA

Presentation

Why a good strategy is not enough

Related topics: Pharmaceutical/Biotech, Market Access & HEOR, Global (non-specific), Capabilities & Effectiveness
Availability: FREE
  • Organisational excellence provides the bridge from strategy to results.
  • What are the building blocks of the bridge and what gets missed.
  • How should we apply organisational excellence to market access strategy.
  • What can we learn from other industries?
Speaker

Janice Haigh
Vice President, Pricing & Market Access
PAREXEL

Presentation

Payer Trackers: A unique opportunity to shift the market access mindset from one of observing to one of shaping payer attitudes

Related topics: Pharmaceutical/Biotech, Market Access & HEOR, Global (non-specific)
Availability: FREE
  • Understanding payer attitudes to optimise business performance.
  • What is the optimal reach and frequency of a payer tracker to maximise impact of such an approach.
  • How can payer trackers can be utilised to leverage business performance.
  • Benefit of payer trackers when sharing information with key internal stakeholders.
Speaker

Santanu Das
Vice President
GFK, UK

Presentation

What is the Future for International Reference Pricing (IRP)

Related topics: Pharmaceutical/Biotech, Market Access & HEOR, Global (non-specific)
Availability: FREE

Most developed countries apply some form of IRP as a factor in negotiating or regulating domestic pricing. With the emergence of risk sharing agreements and in particular confidential price / volume agreements tied to HTA assessments some experts are suggesting the end of IRP systems in imminent. In contrast, some countries like Canada are placing greater reliance on IRP to lower drug prices.

  • Beginnings and Evolution of IRP.
  • Overview of approaches to IRP.
  • Impact of IRP on product launches and HTA.
  • Role of risk-sharing agreements to mitigate impact of IRP.
  • Canadian IRP as a case study.
Speaker

Neil Palmer
Founder & Senior Consultant
PDCI Market Access

Presentation

Digital technology: An enabler of patient, payer and physician engagement

Related topics: Pharmaceutical/Biotech, Market Access & HEOR, Medical Affairs & Stakeholder Engagement, Patient-Centricity & Care, Digital & Technology
Availability: FREE
  • The revolution has already happened in other sectors: Is health next?
  • How is digital technology being deployed along the health value chain?
  • How will technology change patient, physician and payer engagement?
  • Can technology radically change data collection and analysis in clinical trials and the real world and therefore the assessment of value?
Speaker

Giles Thurston
Head of Digital Solutions
Pope Woodhead and Associates Ltd.

Presentation

The impact of PROs on HTA decision-making

Related topics: Pharmaceutical/Biotech, Europe, Market Access & HEOR
Availability: FREE
  • Current perception of PRO evidence among payers and its influence in decision-making 
  • Differences between payer and regulators in assessing PRO evidence
Speaker

Anke van Engen
Principal, Consulting Services
QuintilesIMS

Presentation

Is there a need for a centralised, European HTA agency and predictable, transparent European standards?

Related topics: Pharmaceutical/Biotech, Europe, Market Access & HEOR
Availability: FREE
  • How similar are HTA agencies in methods and procedures?
  • Is there a development towards shared standards?
  • What are stakeholders doing to encourage harmonisation/standardisation?
  • Is there a need for a European institution to get the job done?
Speaker

Finn Boerlum Kristensen
Managing Director Science & Policy, Faculty of Health Sciences, University of Southern Denmark
Former EUnetHTA Executive, Committee Chairman and EUnetHTA Secretariat Director

Presentation

The role of MSLs in the development of pre-market communications

Related topics: Pharmaceutical/Biotech, Medical Affairs & Stakeholder Engagement, Commercial, Global (non-specific), Medical Science Liaison, Life Sciences (not-specific)
Availability: FREE
  • Medical Affairs and MSL synchronicity: Linking efforts to ensure a positive outcome.
  • MSLs and KOLs: The data sweet spot: Finding balance within the current regulatory environment.
  • The role of MSLs in audience engagement: Strategic & tactical approaches to engagement.
  • MSL-directed educational communications: An appropriate path forward.
  • Measuring the impact of MSL-driven activities: Applying metrics to establish impact.
Speaker

Tim Day
Principal 
Innovative Strategic Communications

Presentation

Achieving world-class execution in medical affairs

Related topics: Pharmaceutical/Biotech, USA, Medical Affairs & Stakeholder Engagement, Global (non-specific), Life Sciences (not-specific)
Availability: FREE

With the rise of medical affairs as healthcare’s core scientific partner, industry leaders are reimagining their organizations to achieve a world-class standard–and deliver greater value. Learn how to align engagement strategies to healthcare stakeholders’ scientific goals and interests, based on actionable insights.

Speakers

Robert Groebel 
Vice President - Global Medical Strategy 
Veeva

Brian Harper
Senior Director, Medical Content Strategy
Veeva 

Register to view both free videos and browse premium content (and event documentation).

1457
videos of thought-leading presentations and interactive panel discussions from life science industry visionaries and experts
300+
new videos added every year!